Indications and uses
relieves redness of the eye due to minor eye irritations for use as a protectant against further irritation or to relieve dryness of the eye for the temporary relief of burning and irritation due to dryness of the eye
relieves redness of the eye due to minor eye irritations for use as a protectant against further irritation or to relieve dryness of the eye for the temporary relief of burning and irritation due to dryness of the eye
Instill 1 to 2 drops in the affected eye(s) up to four times daily.
Store at room temperature
Drug Facts
| Active ingredients | Purposes |
|---|---|
| Glycerin 0.25% | Lubricant |
| Naphazoline hydrochloride 0.012% | Redness reliever |
For external use only
Do not use if solution changes color or becomes cloudy
Ask a doctor before use if you have narrow angle glaucoma
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center (1-800-222-1222) right away.
Instill 1 to 2 drops in the affected eye(s) up to four times daily.
Store at room temperature
benzalkonium chloride, boric acid, edetate disodium, purified water, sodium borate
1-877-274-1787
www.cleareyes.com
Distributed by Lil' Drug Store Products Inc.
9300 Earhart Lane SW, Cedar Rapids, IA 52404
UP TO
12
HOURS OF
SOOTHING
COMFORT
NEW
LOOK!
SAME
COMFORT
TRANSFORM YOUR DAY™
CLEAR
EYES ®
REDNESS
RELIEF
Relieves:
redness,
dryness,
burning &
irritation
This Package for
Households Without
Young Children
CONVENIENT
PAL™
Formulated to
Relieve Redness
& Moisturize
Soothes &
Protects
Fast-Acting
LUBRICANT/REDNESS RELIEVER
EYE DROPS | STERILE 0.2 fl oz (6mL)
[Lil' Drug Store logo]
UP TO
12
HOURS OF
SOOTHING
COMFORT
NEW
LOOK!
SAME
COMFORT
TRANSFORM YOUR DAY™
CLEAR
EYES®
REDNESS
RELIEF
Relieves:
redness,
dryness,
burning &
irritation
This Package for
Households Without
Young Children
CONVENIENT
PAL™
Formulated to
Relieve Redness
& Moisturize
Soothes &
Protects
Fast-Acting
LUBRICANT/REDNESS RELIEVER
EYE DROPS | STERILE 0.2 fl oz (6mL)
[Lil' Drug Store logo]
| Class | Version | Type | Effective |
|---|---|---|---|
| GLYCERIN Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| e18001c8-33ae-5f66-9cdc-a39724bd4573 | Product name | 1 | 20140508 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 66715-7010-3 | Cleareyes Redness Relief | 1 in 1 PACKAGE | LIQUID | 1 | 4 | |
| 66715-7010-3 | Cleareyes Redness Relief | 6 mL in 1 BOTTLE, DROPPER | LIQUID | 6 | 4 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 66715-7010 | CLEAREYES REDNESS RELIEF (NAPHAZOLINE HYDROCHLORIDE AND GLYCERIN) LIQUID [LIL' DRUG STORE PRODUCTS, INC.] | 4 | Current NDC, Legacy NDC, 2 package rows | 20231216_39e4ab2b-ae12-4339-b219-109cf0f7f06a.zip |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 66715-7010 | 66715-7010-3 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| BENZALKONIUM CHLORIDE | F5UM2KM3W7 | IACT |
| BORIC ACID | R57ZHV85D4 | IACT |
| EDETATE DISODIUM | 7FLD91C86K | IACT |
| WATER | 059QF0KO0R | IACT |
| SODIUM BORATE | 91MBZ8H3QO | IACT |
| NAPHAZOLINE HYDROCHLORIDE | MZ1131787D | ACTIB |
| GLYCERIN | PDC6A3C0OX | ACTIB |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cleareyes Redness Relief | NAPHAZOLINE HYDROCHLORIDE AND GLYCERIN | Lil' Drug Store Products, Inc. | 39e4ab2b-ae12-4339-b219-109cf0f7f06a | 2023-12-15 | Warnings | 66715-7010-3 66715-7010 66715701003 0c8f4454-0523-b87a-e063-6394a90aa9b7 39e4ab2b-ae12-4339-b219-109cf0f7f06a |
Adverse event summaries are temporarily unavailable. Other product information remains available.